A novel blood-based test that can help differentiate between schizophrenia and bipolar disorder may ...
The Food and Drug Administration (FDA) this week requested that manufacturers of glucagon-like pepti...
January The FDA approves the esketamine nasal spray Spravato as a monotherapy for adults with treatm...
Only 19% of Americans are familiar with kratom, a plant touted as a “natural opiate” and sometimes r...
